Skip to content

Clinical trials

Terminated Phase 2 Schizophrenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 2 Status: Terminated Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20041
20061
20075
20083
20092
20101
20111
20122
20134
20141
20152
20172
20183
20193
20203
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated39

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer3
AbbVie2
Amgen2
H. Lundbeck A/S2
National Institute of Mental Health (NIMH)2
New York State Psychiatric Institute2
Abbott1
Assistance Publique - Hôpitaux de Paris1
AstraZeneca1
Beth Israel Deaconess Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia39
Psychotic Disorders11
Cognitive Dysfunction3
Obesity3
Cognition Disorders2
Mental Disorders2
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Hypertension1
Memory Disorders1

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.